Search research articles
Contact Us
Filters
Showing results (31-40 of 199) with videos related to
Page
of 20
Sort By:
The Journal of Surgical Research
|
June 24, 2020
Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric Cancer
Xuefei Wang, Junjie Zhao, Zhenbin Shen, et al.
Pharmacoeconomics
|
October 14, 2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective
Tingting Qu, Shujing Zhang, Yichen Zhong, et al.
Oncology (Williston Park, N.Y.)
|
September 3, 1998
Irinotecan and cisplatin in upper gastrointestinal malignancies
P C Enzinger, D H Ilson, L B Saltz, et al.
Neurology
|
May 25, 2005
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects
C Enzinger, F Fazekas, P M Matthews, et al.
Cancer
|
April 3, 1999
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma
P C Enzinger, D H Ilson, L B Saltz, et al.
AJNR. American Journal of Neuroradiology
|
March 13, 2010
The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian stroke prevention study
Stefan Ropele, C Enzinger, M Söllinger, et al.
Journal of Neurology
|
May 17, 2005
Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy
P Kapeller, S Ropele, C Enzinger, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 1, 2026
Analysis of quality-adjusted survival time without symptoms or toxicity for pembrolizumab plus chemotherapy as treatment for previously untreated participants with advanced or metastatic esophageal cancer
Ying Zhang, Marc Diez Garcia, Sukrut Shah, et al.
AJNR. American Journal of Neuroradiology
|
December 8, 2000
A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis
S Ropele, S Strasser-Fuchs, M Augustin, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 199) with videos related to
Sort By:
Page
of 20
The Journal of Surgical Research
|
June 24, 2020
Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric Cancer
Xuefei Wang, Junjie Zhao, Zhenbin Shen, et al.
Pharmacoeconomics
|
October 14, 2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective
Tingting Qu, Shujing Zhang, Yichen Zhong, et al.
Oncology (Williston Park, N.Y.)
|
September 3, 1998
Irinotecan and cisplatin in upper gastrointestinal malignancies
P C Enzinger, D H Ilson, L B Saltz, et al.
Neurology
|
May 25, 2005
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects
C Enzinger, F Fazekas, P M Matthews, et al.
Cancer
|
April 3, 1999
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma
P C Enzinger, D H Ilson, L B Saltz, et al.
AJNR. American Journal of Neuroradiology
|
March 13, 2010
The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian stroke prevention study
Stefan Ropele, C Enzinger, M Söllinger, et al.
Journal of Neurology
|
May 17, 2005
Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy
P Kapeller, S Ropele, C Enzinger, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 1, 2026
Analysis of quality-adjusted survival time without symptoms or toxicity for pembrolizumab plus chemotherapy as treatment for previously untreated participants with advanced or metastatic esophageal cancer
Ying Zhang, Marc Diez Garcia, Sukrut Shah, et al.
AJNR. American Journal of Neuroradiology
|
December 8, 2000
A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis
S Ropele, S Strasser-Fuchs, M Augustin, et al.
Page
of 20